Corrigendum to "miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis" [Biomed. Pharmacother. 92 (2017) 1119-1127]
Biomed Pharmacother. 2018 Mar:99:1033-1036.
doi: 10.1016/j.biopha.2018.01.031.
Epub 2018 Feb 2.
1 Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha 410013 Hunan, China.
2 Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha 410013 Hunan, China; Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Changsha 410013, Hunan, China.
3 Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan, China.
4 Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha 410013 Hunan, China; Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Changsha 410013, Hunan, China. Electronic address: [email protected].